Member Info for ahmir121

Well 20% so far lets see where we get xx

Haha lets see.... needs some magic for me to think of selling soon

Good mate ...hope so ...we cant be doing with more negativity from the bod.

Think that plays a huge part ...from what we know for sure its about half the stock is well held? ...suspect the sales after the bad rns and the available stock has most likely been taken up by now ... my regret is timing as most people here could have had so much more stock had i bought now rather than before ... part of trading .. get some news and to the targets and i wont complain about anything lol imo dyor

Makes me luagh the spread on this ...2.50 ask now and sell at 1.75 ! Lol .... its been moved up most likely mms expecting people to want the shares just before the interims..in case it is a good update.... we are all hoping it is... bit of clarity and a upbeat projection please sev ;p

No idea pal out of our control .. try buying in 2 batches instead Just glad to see a bit of a rise for a change lol

Season is upon us ...that is evident my the number of rnss for many companies today ..many releasing half year results /reports but also additional rns ...agreements/new deals must have been planned and held back to release with results .. ..perfect time to do and get the most exposure....hint hint servision ...imo dyor

Hi prof ... Lets see now where they have got from the last rns ....yahoo finance and investing both have thursday down for servision results ..doesnt say a time but i suspect it will be before market.

would also arm the bad press with more ammo ...last thing a company which is planning to move to the big time needs ..they need to start making people believers in the future of sev .... every investor looks at the sp and the history...... currently down from 6p to 2pish is not pretty reading no matter what excuses they come up with ..they need to deliver.

oh and these "contracts" we are/were going for any update would do lol

nothing much i assume pretty much what we know already ..the results for 1st half of 2017..im more interested in the future outlook if it is still bleak...and the update on the plans for main market and any other news on developments.... this cant be another negative i would think it has to have some positives as i dont know where the sp could end up with more bad news .... we have a vital 3-4 weeks ahead of us here .... best case would be some positives in this update and cascade taking up the options ..which should make the sp spike i hope .....worst case is more negativity in this rns and cascade not taking the options ..... the timeline was specific for the next batch oct 20th so assuming this is part of a bigger plan i expect this to be a good rns which hopefully sheds some light on things here/ imo etc dyor

Thursday 28th september Servision (SEVL) -- / -- -- / -- 2.68M showing on the earning calender on investing

hopefully we should be updated in the interim's about the main market listing ? ...going off the previous years and the interims they are pretty well summarized .... so lets hope for some good news on the company because i dont think it can handle further downside and niether can i lol .... and then for cascade to take these options up with a nice contract thrown in ..if only things aligned that perfectly :/.... dyor etc etc

hopefully we should be updated in the interim's about the main market listing ? ...going off the previous years and the interims they are pretty well summarized .... so lets hope for some good news on the company because i dont think it can handle further downside and niether can i lol .... and then for cascade to take these options up with a nice contract thrown in ..if only things aligned that perfectly :/.... dyor etc etc

In addition to the $2 million subscription, Cascade have been granted an option to invest up to a further $4 million, in two equal tranches, at the same Group valuation. The first option period runs until 20 October 2017, with an option price per share of approximately 10.2p per share, and the second option period runs until 29 September 2018, with an option price per share of approximately 9.3p per share. A condition of the Subscription is that if the Group's shares are not listed on either the Main Market of the London Stock Exchange or on Nasdaq, or if the Company has not been sold for a price higher than the Issue Price, before 21 February 2019, then any new capital raised by the Company thereafter must first be used to buy back the Subscription Shares, together with any new ordinary shares issued pursuant to the Options, that are still held by Cascade at the same price(s) as they were issued. Such a buy back would require the Company to have sufficient distributable reserves, which may involve a capital reduction, and would also require shareholder approval. The Company announced on 25 May 2017 that it intends to apply for a Standard Listing on the Market of the LSE during the first half of 2018. In order to apply for admission to the Standard segment of the LSE, the Company must meet certain eligibility criteria and the Company intends to apply to the Financial Conduct Authority in this respect in the next few months.

last two statements on the cascade options one from results one from the trading update................................ ....Cascade Options On 22 February 2017 SerVision plc (the "Company") announced the terms of a subscription ("Subscription") for new ordinary shares of 1 pence each ("Ordinary Shares") in the capital of the Company made by Cascade SVP, LLC ("Cascade") to raise US$2 million. The Subscription was made in two separate tranches with the initial US$1 million being received by the Company on 1 March 2017 resulting in the allotment to Cascade of a total of 7,107,850 new Ordinary Shares at an issue price of 11.3 pence and the second US$1 million being received on 25 May 2017 resulting in the allotment to Cascade of a further 7,107,850 new Ordinary Shares also at an issue price of 11.3 pence each. In addition to the US$2 million subscription, Cascade was granted options ("Options") to invest up to a further US$4.0 million, in two equal tranches at the same valuation as the Subscription. The first tranche ("First Tranche") is an option to subscribe for up to 15,795,222 new Ordinary Shares (being 11.1% of the current issued share capital) at 12.66 cents each (equivalent to approximately 9.97p at today's exchange rate), amounting to up to $2.0 million in aggregate, and exercisable by 20 October 2017. The second tranche ("Second Tranche") is an option to subscribe for up to 17,374,919 new Ordinary Shares at 11.51 cents each (equivalent to approximately 9.06p at today's exchange rate), again amounting to up to $2.0 million in aggregate, and exercisable by 29 September 2018. As at the date of this circular Cascade has a beneficial interest in 14,215,700 Ordinary Shares representing 10.0% of the share capital of the Company. Should Cascade choose to exercise the First Tranche in full, and assuming that no other new Ordinary Shares are issued by the Company, then Cascade would hold up to 19 % of the enlarged issued share capital of the Company. Should Cascade choose to exercise both the First Tranche and the Second Tranche in full, and assuming that no other new Ordinary Shares are issued by the Company, then Cascade would hold up to 27% of the enlarged issued share capital of the Company

Last Trading week of September... im expecting results for 1st half this week ..going off previous years routine and the predictabilty of the bod here......would be great to get some good news before we hear about cascades decision some 4 weeks away ....come on sev ... lets end the year with a bang ....3 months plenty of room for a big upward move hopefully !

With no red dot :/ zzzzzzzzzzzz

hopefully yes.... ....could be something already in place or another integration type of thing ....lets see if any thing is mentioned in the r&d section on he next rns would change the outlook here ..to be a part of the next BIG thing would be huge for sev. imo dyor

would love some clarity on that by servision ..maybe something we will hear on maybe in results as the research department should give a update hopefully imo dyor etc